FIELD: pharmaceutics.
SUBSTANCE: disclosed are pharmaceutical compositions containing diclofenac, and therapeutic methods for using them, which are effective once a day.
EFFECT: disclosed are compositions based on diclofenac for local application and related methods.
34 cl, 17 tbl, 7 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| [(S)-1-CARBAMOYL-2-(PHENYLPYRIMIDIN-2-YLAMINO)ETHYL]AMIDE 2-(2-METHYLAMINOPYRIMIDIN-4-YL)-1H-INDOLE-5-CARBOXYLIC ACID FOR USE IN TREATING OSTEOARTHRITIS-RELATED PAIN | 2015 |
|
RU2687094C2 |
| PHARMACEUTICAL COMPOSITION FOR SAFE AND EFFECTIVE TREATMENT OF KNEE AND/OR HIP JOINT PAIN | 2019 |
|
RU2786232C2 |
| LTA4H INHIBITORS FOR TREATING PURULENT HYDRADENITIS | 2020 |
|
RU2821362C2 |
| METHODS OF TREATING SJOGREN SYNDROME USING BRUTON TYROSINE KINASE INHIBITOR | 2020 |
|
RU2824354C2 |
| TREATING PATHOLOGICAL CONDITIONS OF JOINTS | 2015 |
|
RU2736513C2 |
| DICLOFENAC GEL | 2007 |
|
RU2463038C2 |
| TAPENTADOL FOR TREATMENT CAUSED BY OSTEOARTHROSIS | 2008 |
|
RU2473337C2 |
| COMPOUND FOR TREATING INFLAMMATION | 2010 |
|
RU2520034C2 |
| PHARMACEUTICAL COMPOSITIONS SUITABLE FOR DELIVERY TO JOINT AND THEIR USE IN TREATMENT OF JOINT PAIN | 2019 |
|
RU2810788C2 |
| METHODS OF TREATING CHRONIC SINUSITIS WITH NASAL POLYPS BY ADMINISTERING IL-4R ANTAGONIST | 2015 |
|
RU2734490C2 |
